Microbiological aspects of Fournier's gangrene

International Journal of Surgery

Volumn 40, Issue , 2017, Pages 135-138

  Yilmazlar, Tuncay ^a   Gulcu, Baris ^a   Isik, Ozgen ^a   Ozturk, Ersin ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Empiric antimicrobial therapy; Microbial; Necrotizing fasciitis

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; DAPTOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; BACTERIUM CULTURE; BURKHOLDERIA GLADIOLI; CITROBACTER; CLINICAL ARTICLE; CORYNEBACTERIUM; DISEASE SEVERITY ASSESSMENT; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FOURNIER GANGRENE; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MORGANELLA MORGANII; MORTALITY RATE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS ANGINOSUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; FOURNIER GANGRENE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 85014506784     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2017.02.067     Document Type: Article

References (13)

1. [1] Yilmazlar, T., Ozturk, E., Ozguc, H., Ercan, I., Vuruskan, H., Oktay, B., Fournier's gangrene: an analysis of 80 patients and a novel scoring system. Tech. Coloproctol. 14 (2010), 217–223.
2. [2] Yılmazlar, T., Işık, Ö., Öztürk, E., Özer, A., Gülcü, B., Ercan, I., Fournier's gangrene: review of 120 patients and predictors of mortality. Ulus. Travma Acil Cerrahi Derg. 20 (2014), 333–337.
3. [3] Morpurgo, E., Galandiuk, S., Fournier's gangrene. Surg. Clin. North Am. 82 (2002), 1213–1224.
4. [4] Sorensen, M.D., Krieger, J.N., Rivara, F.P., Broghammer, J.A., Klein, M.B., Mack, C.D., Wessells, H., Fournier's Gangrene: population based epidemiology and outcomes. J. Urol. 181 (2009), 2120–2126.
5. [5] Katib, A., Al-Adawi, M., Dakkak, B., Bakhsh, A., A three-year review of the management of Fournier's gangrene presented in a single Saudi Arabian institute. Cent. Eur. J. Urol. 66 (2013), 331–334.
6. [6] Bjurlin, M.A., O'Grady, T., Kim, D.Y., Divakaruni, N., Drago, A., Blumetti, J., Hollowell, C.M., Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology 81 (2013), 752–759.
7. [7] Smaldone, M., Corcoran, A., Davies, B., Fournier gangrene: advances in clinical management. AUA Update Ser. 29 (2010), 170–179.
8. [8] Yanar, H., Taviloglu, K., Ertekin, C., Guloglu, R., Zorba, U., Cabioglu, N., Baspinar, I., Fournier's gangrene: risk factors and strategies for management. World J. Surg. 30 (2006), 1750–1754.
9. [9] Sandiumenge, A., Rello, J., Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr. Opin. Pulm. Med. 18 (2012), 187–193.
10. [10] Eke, N., Fournier's gangrene: a review of 1726 cases. Br. J. Surg. 87 (2000), 718–728.
11. [11] Yilmazlar, T., Fournier gangreni: Sinsi, Öldürücü, Ancak Tedavi Edilebilir Hastalık. Kolon Rektum Hast Derg. 22 (2012), 45–49.
12. [12] Koenig, S.M., Truwit, J.D., Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin. Microbiol. Rev. 19 (2006), 637–657.
13. [13] Siempos, I.I., Vardakas, K.Z., Kyriakopoulos, C.E., Ntaidou, T.K., Falagas, M.E., Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis. Shock 33 (2010), 590–601.